Search

CTV News in Canada has done a feature on phage therapy, which follows a Canadian cystic fibrosis patient as she travels to Yale University for phage treatment.

Bas Dutilh We are thinking about making virus taxonomy more consistent with the rest of biology by introducing binomial species nomenclature. You know: genus name & species epithet. Do you have an opinion about this? Let us know: Paper | IC

Outstanding candidates are invited to apply for independent group leader positions in any of the 12 scientific departments on its campus in Paris, France. Institut Pasteur is a non-profit private foundation dedicated to fundamental, interd

Recently, it has been demonstrated that inherited symbionts may protect their hosts from certain pathogens. Such protective phenotypes are potentially beneficial in terms of host fitness, and thus could aid symbiont establishment. This pred

Ael Hardy Has anyone successfully performed proteomics (LC-MS) on whole phage particles (not bands from SDS-PAGE gels)? Looking for alternative protocols as the one I have been trying has given me a hard time. — @ael_hardy, via Twitter

Bas Dutilh We are thinking about making virus taxonomy more consistent with the rest of biology by introducing binomial species nomenclature. You know: genus name & species epithet. Do you have an opinion about this? Let us know: Paper | IC

Anushila Chatterjee (University of Colorado) and colleagues have used transposon library screening and RNA sequencing to thoroughly investigate the interaction of E. faecalis with a virulent phage. They show that phage predation can influen

Xiaofang Wang (Nanjing Agricultural University) and colleagues have studied the efficacy of different phage combinations on Ralstonia solanacearum infection of tomato plants, and found that increasing the number of phages used at a time dec

The not-for-profit healthcare organization Hackensack Meridian Health has invested in the phage biotech company Adaptive Phage Therapeutics (APT). According to APT's CEO, Greg Merril, "The high level of interest from strategic and financial

The Swiss National Science Foundation (SNSF) has announced its support of a phage project through a Sinergia Grant of more than CHF 3 million. This is a joint project between Prof. Martin Loessner of ETH Zurich, Prof. Jonas Marschall of Ber

Applications for the Pharmabiotics 2020 Young Investigators Awards are now open! This is a co-initiative by the Pharmabiotic Research Institute (PRI) and Institut Mérieux. An award of €10,000 will be allocated to a young clinician or academ

Are you attending the International Conference on Bacteriophage Research and Antimicrobial Resistance next week (Dec 12-13) in Vellore, India?

Outstanding candidates are invited to apply for independent group leader positions in any of the 12 scientific departments on its campus in Paris, France. Institut Pasteur is a non-profit private foundation dedicated to fundamental, interd

Recently, it has been demonstrated that inherited symbionts may protect their hosts from certain pathogens. Such protective phenotypes are potentially beneficial in terms of host fitness, and thus could aid symbiont establishment. This pred

Ael Hardy Has anyone successfully performed proteomics (LC-MS) on whole phage particles (not bands from SDS-PAGE gels)? Looking for alternative protocols as the one I have been trying has given me a hard time. — @ael_hardy, via Twitter

The not-for-profit healthcare organization Hackensack Meridian Health has invested in the phage biotech company Adaptive Phage Therapeutics (APT). According to APT's CEO, Greg Merril, "The high level of interest from strategic and financial

Xiaofang Wang (Nanjing Agricultural University) and colleagues have studied the efficacy of different phage combinations on Ralstonia solanacearum infection of tomato plants, and found that increasing the number of phages used at a time dec

Applications for the Pharmabiotics 2020 Young Investigators Awards are now open! This is a co-initiative by the Pharmabiotic Research Institute (PRI) and Institut Mérieux. An award of €10,000 will be allocated to a young clinician or academ

The 2nd Hanson Wade Bacteriophage Therapy Summit will take place March 24-26, 2020 in Boston. Key speakers include representatives from the FDA and the EMA, as well as leaders of several phage biotech companies.

I am working on isolation and characterisation of marine phages for anti-bio fouling activity. Our lab has assessed the influence of chlorine on different marine microorganisms as well as barnacles, and now we are looking into use of marine